Treatment of Acne Vulgaris During Pregnancy and Lactation
Authors:
- 9 May 2013
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 73 (8) , 779-787
Abstract
Acne vulgaris is a common problem encountered by pregnant and lactating women. Unfortunately, in clinical practice, treatment is often not optimized as a result of the lack of safety data and unified recommendations on the use of the various anti-acne therapies. In this narrative review, current data on their safety is summarized. We recommend the use of topical medications as first-line treatment for acne vulgaris in pregnant and lactating women. These include antibiotics (erythromycin, clindamycin, metronidazole and dapsone), benzoyl peroxide, azelaic acid and salicylic acid. Oral agents and/or light-based therapy may be considered as second-line treatment. The former consists of oral macrolides (erythromycin and azithromycin), cephalexin or zinc compounds. Blue–violet or red light phototherapy may be used as monotherapy or in addition to topical and/or oral therapies. Hormonal therapy, antibiotics consisting of tetracyclines, co-trimoxazole and fluoroquinolones, and both oral and topical retinoids should be avoided.Keywords
This publication has 47 references indexed in Scilit:
- Pregnancy Outcome Following Exposure to Topical Retinoids: A Multicenter Prospective StudyThe Journal of Clinical Pharmacology, 2012
- Guidance on the diagnosis and clinical management of acneClinical and Experimental Dermatology, 2012
- Considerations when prescribing trimethoprim-sulfamethoxazoleCanadian Medical Association Journal, 2011
- Isotretinoin and iPledge: A view of resultsJournal of the American Academy of Dermatology, 2011
- Retinoid plus antimicrobial combination treatments for acneClinical, Cosmetic and Investigational Dermatology, 2011
- Oral Cephalexin for Acne Vulgaris: Clinical Experience with 93 PatientsPediatric Dermatology, 2008
- Guidelines of care for acne vulgaris managementJournal of the American Academy of Dermatology, 2007
- Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancyAmerican Journal of Medical Genetics Part A, 2005
- Risk of Infantile Hypertrophic Pyloric Stenosis after Maternal Postnatal Use of MacrolidesScandinavian Journal of Infectious Diseases, 2003
- Use of oral and topical agents for acne in pregnancyJournal of the American Academy of Dermatology, 1988